Literature DB >> 12323072

Public financial support for disability at the dawn of the 21st century.

David L Braddock1.   

Abstract

This is an empirical study of contemporary public financial support for disability in the United States. Public support for disability programs in the United States totaled dollars 294 billion in 1997 (41.5 million recipients) and was estimated to be dollars 426 billion in 2002. Nationally, 52% of public long-term care financial resources supported persons with disabilities in institutions, although great variation existed among states and across disability groups (i.e., mental retardation, mental illness, physical disability). State financial commitments for community long-term care services for each of the three disability groups was strongly associated with state participation in the Medicaid HCBS Waiver and Personal Assistance programs and for persons with MR/DD, with states' early adoption of civil rights statutes promoting racial equality.

Entities:  

Mesh:

Year:  2002        PMID: 12323072     DOI: 10.1352/0895-8017(2002)107<0478:PFSFDA>2.0.CO;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  4 in total

1.  County-level variation in the prevalence of medicaid-enrolled children with autism spectrum disorders.

Authors:  David S Mandell; Knashawn H Morales; Ming Xie; Daniel Polsky; Aubyn Stahmer; Steven C Marcus
Journal:  J Autism Dev Disord       Date:  2010-10

2.  Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999.

Authors:  David S Mandell; Jun Cao; Richard Ittenbach; Jennifer Pinto-Martin
Journal:  J Autism Dev Disord       Date:  2006-05

3.  Brief report: Quantifying the impact of autism coverage on private insurance premiums.

Authors:  James N Bouder; Stuart Spielman; David S Mandell
Journal:  J Autism Dev Disord       Date:  2009-02-13

4.  Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.

Authors:  David S Mandell; Knashawn H Morales; Steven C Marcus; Aubyn C Stahmer; Jalpa Doshi; Daniel E Polsky
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.